Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

12.70
Delayed Data
As of 4:00pm ET
 -0.15 / -1.17%
Today’s Change
9.30
Today|||52-Week Range
20.45
+4.96%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close12.85
Today’s open12.90
Day’s range12.60 - 13.05
Volume265,729
Average volume (3 months)567,671
Market cap$890.3M
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+41.87%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+212.77%
P/E ratioNM
Price/Sales86.33
Price/Book3.70

Competitors

----
SGMOSangamo Therapeutics...-0.10-0.66%
RTRXRetrophin Inc+0.14+0.66%
FPRXFive Prime Therapeut...-0.02-0.07%
Data as of 4:00pm ET, 11/22/2017

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$8.0M
Annual profit (last year)-$110.2M
Net profit margin-1,376.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts